Advances in human papillomavirus therapeutic vaccine / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 685-690, 2007.
Artículo
en Chino
| WPRIM
| ID: wpr-298758
ABSTRACT
Human papillomavirus (HPV) infection is very common but with limited therapies available. Although the prophylactic vaccination will be promoted worldwide soon, it can only show its benefits decades later. For individuals who already have established infections and dysplasias, it has little efficacy. In contrast, the therapeutic vaccines bridge the temporal deficit by fighting against the established HPV infections and HPV-related diseases. HPV oncogenes may be delivered in viral and bacterial vectors, in peptides or protein, in nucleic acid form, or in cell-based vaccines. This review summarizes the clinical trials of HPV therapeutic vaccines under the way and the different preclinical research strategies that are under investigations.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Terapéutica
/
Virología
/
Condiloma Acuminado
/
Enfermedades del Cuello del Útero
/
Displasia del Cuello del Útero
/
Neoplasias del Cuello Uterino
/
Vacunas contra el Cáncer
/
Infecciones por Papillomavirus
/
Usos Terapéuticos
/
Vacunas contra Papillomavirus
Límite:
Animales
/
Femenino
/
Humanos
Idioma:
Chino
Revista:
Acta Academiae Medicinae Sinicae
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS